The World Health Organization in Egypt confirmed that the possibility of transmitting the Corona virus from shoes and infecting individuals is very weak, as it tweeted through the official Twitter account, saying: “The possibility of Covid 19 transmitting from shoes and infecting individuals is very low and for precaution, especially in homes where babies and children crawl or play “The kids are on the floor. Be sure to leave your shoes at the entrance to your home, as this will prevent contact with any dirt or debris that may stick to the sole of the shoes.”
— WHO Egypt (@WHOEgypt) September 20, 2020
On the other hand, the World Health Organization approved a protocol that regulates the conduct of tests on African herbal medicines as potential treatments for Corona virus and other epidemic diseases, and the organization indicated, in a statement reported by the American Al-Hurra channel on Sunday, that the third phase of clinical tests (for a group of up to 3) Thousands of test subjects) pivoted to fully assess the safety and efficacy of new medicinal products.
“If the safety, efficacy and quality of a traditional medicine product is demonstrated, the World Health Organization will recommend it for rapid and large-scale local manufacture,” WHO Regional Director Prosper Tomosemi said.“.
Tomosimi added that the emergence of Covid-19, such as the Ebola outbreak in West Africa, has highlighted the need for strong health systems and accelerated research and development programs, including traditional medicine..
The organization approved the protocol in partnership with the African Center for Disease Control and Prevention and the African Union Commission for Social Affairs.
The World Health Organization also said that the expert committee that it formed in cooperation with the African Center for Disease Control and Prevention and the African Union Commission for Social Affairs approved the third phase protocol for clinical trials of herbal medicines for treating Corona virus, in addition to a charter and terms of reference for establishing a data and safety monitoring board for clinical trials of herbal medicine.